GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the appeal rule is doing its job and people should stop complaining — 30 comments in the full submission. View in context.
540
c/insurancefights·submitted 2 years ago by u/karim_restrepo

[Meta] the appeal rule is doing its job and people should stop complaining

Appealbranch of 6 comments

Right, the denial question again, but with numbers this time. I have 5 data points over 16 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…

Read the full submission and all 30 comments →

This branch

6 comments, started 2 years ago
u/cato_achebe39 points·2 years ago·edited

This is correct. Appeal letters work.

replysharereportpermalink
u/honest_syringe1910 points·2 years ago

say which country and which plan type

replysharereportpermalink
u/osman_ferrari12 points·2 years ago

say which country and which plan type

Disagree on that part. 93.7% and 99.3% on the same vial is normal.

replysharereportpermalink
u/saskia_rahimi8 points·2 years ago

Slight fix: the number was 99.0, not 98.9. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/sofia_nascimento2 points·2 years ago

What was the denial code?

replysharereportpermalink
u/tidy_vialdrawer_watch12 points·2 years ago

copay is separate from coverage

replysharereportpermalink

← back to the whole thread

About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.